




The thesis entitled “Synthetic studies towards bioactives (+)-Asenapine and (-)-
Englerin A” is presented in three chapters. 
General introduction of Ireland-Claisen rearrangement 
In 1972, for first time Ireland-Claisen rearrangement was introduced and since then 
this reaction is widely used in the synthesis of natural products. The starting materials 
can be prepared easily by the coupling an allylic alcohol with carboxylic acid with 
excellent yields, product diastereoselectivity and atom economy.Ireland-Claisen 
rearrangement is a [3, 3]-sigmatropic shift of allylic ester which produce γ, δ-
unsaturated acid. The rearrangement proceeds through chair like transition state. The 
allylic ester when subjected with base in presence of TBSCl initially forms an enolate 
which is stabilized by forming TBS ketene acetal. If there is a substitution at alpha 
positition of allylic ester, it can produce E and Z enolates which are responsible for 
the stereo chemical outcome. The formation of E and Z enolates are controlled by 
changing the reaction conditions.  
 
Statement of problem 
Chapter I: Total synthesis of (+)-Asenapine 
 This chapter describes the total synthesis of (+)-asenapine which is approved by FDA 
in 2009 for the treatment of schizophrenia. Asenapine is a synthetic drug which is 
developed by altering the structure of mianserin. Mianserin is an anti psychoactive 
drug which belongs to tetracyclic antidepressant (TeCA) therapeutic family. 
Asenapine is used for treatment of schizophrenia and acute manic or mixed episodes 
(bipolar disorders). This drug, when administered, enhances the extracellular 
dopamine concentration in the medial prefrontal Cortex (mPFC) and is also found to 
enhance the transmission of NMDA in the mFPC. The total synthesis of asenapine in 
racemic form is reported in the literature. The chemical structure of (±)-asenapine can 





 positions with chlorophenyl, phenyl ether in a trans geometry. Interestingly, 





based on preclinical data, the FDA has approved the market launch with the racemic 
version. It would be worthy an effort to develop a strategy which enables one to 
synthesise any of the possible four isomers by choosing the appropriate starting 
materials albeit the same synthetic sequence. The synthetic challenges posed by the 
asenapine structure were influencial in taking up its total synthesis.  
Chapter II: Synthesis of Asenapine analogues as neurotrophic agents 
Schizophrenia is a disorder characterized to be both neuro-degenerative and neuro- 
developmental. Research in this area has identified the role of genes in the 
manifestation of this disease from what appears to be a normal childhood. In addition 
to genetic factors, environmental factors play a substantial role in the development of 
neurons. It has been thought that psychotropic drug molecules act through their 
neurotransmitter action. Bodnar et al. have reported that chronic activation of post 
synoptic 5-HTLA receptor may encourage neurite growth in hippocampus and 
regulation of BDNF. As asenapine is a 5-HT eceptor and we envisioned to explore the 
relation between BDNF and 5-HT receptor activity. To determine this some of the 
advanced intermediates, their derivative and asenapine analogues were screened for 
BDNF signaling. 
 
Chapter III: Synthetic efforts towards (-)-Englerin A 
Beutler et al. isolated guanine sesquiterpene from the stem bark of Phyllanthus sp in 
2009, and named them as englerin A (1), englerin B (2) and englerin B acetate (3). 
Englerin A (1) is characterized as a tricyclic (5-6-5) skeleton with ether bridge and it 
has cinnamic acid (C6) and glycolic acid (C9) residue. Englerin B (2) and englerin B 
acetate (3) showed significant loss of potency and selectivity toward renal cancer 
cells. Englerin A (1) has been used as a lead compound for drug discovery, due to its 
significant cytotoxic activity against six human cancer cell lines. It binds to TRPC 
protein tetramers (four cylinders) in a kidney cancer cell membrane. This opens the 
central ion channel, which allows Ca
2+
 into the cell and leads to cell death. Our 
group’s interest in the total synthesis of natural products and the synthesis of 
bioactives of marine origin is the driving force which embarks on the total synthesis 









Chapter I: The total synthesis of (+)-asenapine 
The retrosynthetic analysis of the (+)-asenapine framework could be obtained from 
synthon (2) through Ullmann coupling, which could be built from (3), which in turn 
could be realised from ester (4) via Ireland-Claisen rearrangement. The intermediate 
(4) could be built from alcohol (5) and 2-bromo phenyl acetic acid (6). Alcohol 
synthon (5) can be accessed from commercially available (S)-ethyl lactate (7) 
(Scheme 1). 
Scheme 1 
The synthetic plan was executed by choosing commercially available (S)-ethyl lactate 
(7), which was protected with TBSCl and reduced to alcohol (8). The alcohol in 
compound (8) was converted to thiotetrazole (9) under Mitsunobu conditions in 92% 
yield. A smooth oxidation of (9) with ammonium molybdate and H2O2 yielded 




Reagents and conditions: a) TBSCl, imidazole, DCM, 0 
o
C to rt, 2 h, 96%; b) DIBAL-H, DCM, 0 
o
C 
to rt, 4 h, 62%; c) TPP, DIAD, PTSH, THF, 0 
o
C to rt, 3 h, 92%; d) (NH4)6Mo7O24 .4H2O, 30% H2O2, 
EtOH, 0 
o
C to rt, 12 h, 87%; e) 5-chloro-2-methoxy benzaldehyde (11), KHMDS, THF, -78 
o
C, 2 h, 
70%; f) TBAF, THF, 0 
o
C to rt, 6 h, 86%. 
 
The olefination between 2-methoxy-4-chloro benzaldehyde (11) and sulfone (10) was 
accomplished with KHMDS as base to isolate the (E)-styrene derivative (12) in 70% 
yield. The silyl ether in (12) was unmasked to alcohol (5) with TBAF (Scheme 2). 
The Mitsunobu reaction between alcohol (5) and o-bromophenylacetic acid (6) was 




to yield allyl acetate derivative (4) 
in 83% yield. The anionic Claisen rearrangement
 





TBSCl and HMPA as additive, in THF and subsequent esterification (after CH2N2 
reaction) provided a diastereomeric mixture of esters (3) and epi-(3) (9:1 ratio), in 
85% yield. The additive HMPA is known to stabilize the (Z)-transition state of enolate 
to furnish the anti-product in major ratio which can be separated by column 
chromatography. With The olefinic functionality in (3) was subjected to oxidative 
cleavage under OsO4/ NaIO4 conditions to obtain aldehyde (13) in 75% yield which 
was further reduced with excess of DIBAL-H to diol (14) in 53% yield. The N-
methylpyrrolidine ring was constructed via tosylation followed by treatment with 
aqueous methylamine in acetonitrile to generate the tricyclic core (2) in 57% yield 
over two steps. Demethylation was achieved with BBr3 in CH2Cl2 to provide phenol 
derivative (15) in 83% yield. The oxepine ring was constructed from (15) using 




Reagents and conditions: a) DIAD, PPh3, THF, 0 
o
C, 4 h, 83%; b) i) LDA, TBSCl, HMPA THF, -78 
o
C to rt 12 h; c) CH2N2, Et2O, 0 
o
C 0.5 h, 85%; d) OsO4 (cat), NaIO4, THF/H2O, (3:1), 0 
o
C, 12 h, 75%; 
e) DIBAL-H, CH2Cl2, 0 
o
C to rt, 6 h, 53%; f) i) TsCl, Pyridine, -15 
o
C to -10 °C, 12 h; ii) aq. 40% 
CH3NH2, CH3CN  60 
o
C, 12 h, 57%; g) BBr3, CH2Cl2, -78 
o
C to  0 
o
C to rt, 3 h, 83%; h) Cs2CO3, CuI, 
1,4-dioxane, reflux, 12 h, 71%.  
Conclusion 
In summary, enantiopure (+)-asenapine has been synthesized employing Julia 
olefination and Ireland-Claisen rearrangement as key reactions. The synthesis was 








Chapter II: Synthesis of asenapine analogues as neurotrophic agents 
The synthetic plan was executed by choosing commercially available (S)-ethyl lactate 
(7), which was converted to the alcohol derivative (5) in 28.6% overall yield. 2-
bromophenylacetic acid (6) was coupled with chiral alcohol (5) in the presence of 
DCC/DMAP to furnish ester (4a).  
 
                                                                                       Scheme 4 
Reagents and conditions: (a) 2-bromo phenylaceticacid (6), DCC, DMAP, CH2Cl2, 0 
o
C, 4 h, 88%; (b) 
LHMDS, TMSCl, THF, -78 
o
C to rt 12 h, 80%; (c) CH2N2, Et2O, 0 
o
C, 0.5 h, 85%; (d) OsO4 (cat), 
NaIO4, THF/H2O (3:1), 0 
o
C, 12 h; (e) DIBAL-H, CH2Cl2 0 
o
C to rt, 6 h, 51%. 
Enolic ester (4a) was then subjected to sigmatropic rearrangement by using 
LiHMDS/TMSCl for a smooth reaction to give an acid (16b) with an excellent 
diastereoselectivity. The esterification of acid 16b in the presence of CH2N2 afforded 
ester (3b) in 85% yield. Compound (3b) was dihydroxylated by using osmium 
tetroxide and NMO followed by oxidative cleavage using sodium periodate provided 
an aldehyde. The resultant aldehyde was subjected to DIBAL-H reduction to produce 
diol (14a) (Scheme 4). Free acid (16b) was coupled with two bases N-methyl 
piperidine and morpholine under EDC/HOBt conditions to get amide analogues (17) 
and (18) (Scheme 5). In addition to these compounds all advanced intermediates were 
screened for their neurotrophic activity (Figure 1). 
 











A set fifteen closely related compounds derived from asenapine were synthesized. 
Screening against 5-HT inhibition has been taken up. BDNF inhibitory studies on the 
fifteen compounds indicated that asenapine and intermediate (3) showed comparable 
activity. 
Chapter III: Synthetic efforts towards (-)-Englerin A 
The retrosynthetic analysis of Englerine A (19) is depicted in scheme 6. The ether 
bridge could be accessed from intramolecular epoxide opening of compound (20). 
The tetrasubstituted double bond of compound (20) could be derived from bicyclic 
compound (21) by aldol condensation. Compound (21) could be achieved from 
commercially available (R)-Limonene. 
 
                                                                   Scheme 6 
The synthesis began with (R)-Limonene (22) as a chiral starting material. Thus, 
controlled ozonolysis of (R)-Limonene (22) followed by intromolecular aldol 





(24) on treating with 4-bromobut-1-ene yielded alcohol (25) which was oxidized with 
Dess-Martin periodinane (DMP) to give ketone (26). The formation of bicyclic enone 
was mediated by RCM reaction using Grubbs 2
nd
 generation catalyst which was 
further subjected to admix-β yielded diol (27). This diol (27) was protected with 2,2-
DMP to furnish compound (28). The selective hydrogenation of the compound (28) 
with 10% palladium over charcoal as a catalyst in ethyl acetate furnished the saturated 
bycyclic enone (21) in 80% yield. The relative stereochemistry of compound (21) was 
established by NOESY correlations. The aldol condensation between bicyclic 
compound (21) and acetone in the presence of LDA and ZnCl2 in THF at -78 
o
C 
afforded bicyclic alcohol (30). Dehydration of alcohol (30) with Burgess reagent 
(MeO2CN-SO2NEt3) gave alkene (31) in 95% yield. The migration of double bond 
was observed using K2CO3 in methanol under reflux condition to produce conjugated 
enone (20). Epoxidation of (20) with hydrogen peroxide gave compound (32). 
Unfortunately regioselective opening of epoxide (32) to give (38) was not successful; 
however formation of (33) was observed (Scheme 7).Deprotection of (20) with p-
methyl sulphonic acid produced diol which on epoxidation with hydrogen peroxide 
gave compound (35) in 85% yield. Secondary alcohol (35) was coupled with acid 
chloride (36) in the presence of pyridine to furnish ester (37) in 86% yield. The 
etherification of compound (37) in presence of Lewis acid gave tricyclic alchohol (39) 
(Scheme 8).  
      
 
Scheme 7 
Reagents and conditions: (a) O3, MeOH, -78 
o
C, 86%; (b) AcOH, piperidine, benzene, reflux, 85%; 
(c) Li, 4-bromobut-1-ene, THF, 0 
o
C 1 h, 71%; (d)  IBX, DMSO, rt, 3 h, 85%; (e) Ti(OiPr)4, Grubbs' 





h, 97% (h) Pd-C/H2, EtOAc, 4 h, 81% (i)  LDA, ZnCl2, acetone, -78 
o
C, 4 h, 85% (j) Burgess reagent, 
PhCH3, 110 
o
C, 1 h, 95% (k) K2CO3, MeOH, reflux, 6 h, 95% (l) 30% H2O2, 10% NaOH, CH3OH  0 
o
C 
to r.t 6 h, 72% (m) In(OTf)3, CH3CN, H2O (20:1), 80 
o




Reagents and conditions: a) pTSA, MeOH, rt, 12  h, 92%; (b) 30% H2O2, MeOH, 0 °C to rt, 6 h 85% 
(c) 11, pyridine, 0 °C to rt 1 h, 86% (d) InCl3, CHCl3, reflux, 4 h, 60%. 
Conclusion 
In conclusion enantioselective synthesis of fully functionalized tricyclic skeleton of (-
)-Englerin A is completed. 
 
